Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
Frontiers | Alzheimer's disease: a mini-review for the clinician
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy | Nano Letters
Biomolecules | Free Full-Text | Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Cells | Free Full-Text | Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
